FDA Warns Of Serious Adverse Events, Including Clots, Strokes, With 2 LVADs
SILVER SPRING, Md. — The Food and Drug Administration on Aug. 5 warned health care providers about serious adverse events associated with left ventricular assist devices (LVADs), including the HeartMate II...To view the full article, register now.
Already a subscriber? Click here to view full article